The dedicated “Lp (a) clinic”: a concept whose time has arrived?

S Tsimikas, ESG Stroes - Atherosclerosis, 2020 - Elsevier
The emergence of pathophysiological, epidemiologic, and genetic data strongly supports
the causality for lipoprotein (a)[Lp (a)] in cardiovascular disease (CVD) and calcific aortic …

Lipoprotein (a) and the atherothrombotic process: mechanistic insights and clinical implications

AM Scanu - Current atherosclerosis reports, 2003 - Springer
Although many epidemiologic studies have pointed at an association between plasma
levels of lipoprotein (a)(Lp (a)) and cardiovascular risk, the data obtained have been …

Lipoprotein (a): Knowns, unknowns and uncertainties

M Ruscica, CR Sirtori, A Corsini, GF Watts… - Pharmacological …, 2021 - Elsevier
Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …

Lp (a)(lipoprotein [a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank

AP Patel, M Wang, JP Pirruccello… - … , and vascular biology, 2021 - Am Heart Assoc
Objective: Lp (a)(lipoprotein [a]) concentrations are associated with atherosclerotic
cardiovascular disease (ASCVD), and new therapies that enable potent and specific …

Lipoprotein (a) in atherosclerotic diseases: from pathophysiology to diagnosis and treatment

S Lampsas, M Xenou, E Oikonomou, P Pantelidis… - Molecules, 2023 - mdpi.com
Lipoprotein (a)(Lp (a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to
apolipoprotein (a). Increased Lp (a) levels are an independent, heritable causal risk factor …

Differences in Lp [a] concentrations and apo [a] polymorphs between black and white Americans

SM Marcovina, JJ Albers, E Wijsman, Z Zhang… - Journal of lipid …, 1996 - Elsevier
Lp [a] concentrations in nmol/L and apo [a] size isoforms, expressed in terms of the relative
number of apo [a] kringle 4 (K4) repeats, were determined in 3959 whites and blacks from …

Does apolipoprotein (a) heterogeneity influence lipoprotein (a) effects on fibrinolysis?

L Hervio, MJ Chapman, J Thillet, S Loyau… - 1993 - ashpublications.org
High plasma levels of lipoprotein (a)[Lp (a)] are considered to be an independent risk factor
for premature cardiovascular disease and are inversely associated with apolipoprotein …